Newsroom

You are here

For the media

Contact Caroline Marin at 612-624-5680 to request an interview with an expert from any one of our health sciences programs. She will work with our entire public relations team to ensure your request is handled immediately.

University of Minnesota, Tufts University part of global workforce development against emerging pandemic threats

Monday, November 24, 2014

When a new pandemic threat like this year’s Ebola outbreak emerges, the importance of preventing and limiting disease spread becomes apparent. Well-trained global health professionals play a key role in preventing and responding to emerging zoonotic disease.

UMN research identifies new anti-bacterial coating for dental implants

Monday, November 10, 2014

University of Minnesota researchers have developed a novel coating for the titanium used in dental implants. The coating kills bacteria on contact and prevents biofilm buildup that can cause infection and implant failure. Researchers hope the coating could be used in prosthetics, medical implants and medical devices used in the body. The findings were published in PLOS ONE.

Survival rates in pediatric umbilical cord transplants may indicate a new standard of care

Wednesday, October 29, 2014

A new standard of care for children facing acute myeloid leukemia (AML) may be clear, following a multi-year study published in the latest edition of the New England Journal of Medicine

The research, led by John Wagner, Jr., M.D., director of the Pediatric Blood and Marrow Transplantation program at the University of Minnesota and a researcher in the Masonic Cancer Center, University of Minnesota, compared outcomes in children with acute leukemia and myelodysplastic syndrome who received transplants of either one or two units of partially matched cord blood. The study was conducted at multiple sites nationwide, between December 2006 and February 2012. Coordinating the study was the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) in collaboration with the Pediatric Blood and Marrow Transplant Consortium and the Children’s Oncology Group.

While the study found similar survival rates in both arms of the study, survival was overall better than in prior reports.  This could create a new standard of care for pediatric patients for whom there is often an adequate single unit and adults for whom there is the need for a double unit should a single unit with an adequate number of blood forming stem cells may not exist.